3 next-generation weight-loss drugs at different stages of FDA review and trials

3 next-generation weight-loss drugs at different stages of FDA review and trials
The next weight-loss drugs to watch are CagriSema, retatrutide and aleniglipron, three obesity candidates at different stages of testing and FDA review, and only one has been filed

Take Your Experience to the Next Level

New

Download our mobile app for a faster and better experience.

Google Play
App Store

Comments

0
U

Join the discussion

Sign in to leave a comment

0:000:00